Olympia Industri (521105)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a 34% discount to book value: P/B 0.66 versus book value ₹91.38, offering a tangible margin of safety.
• Trailing P/E of 10.52 and PEG of 0.32 suggest the market is not paying richly for growth, if earnings growth is sustainable.
• Piotroski F-Score of 7/9 points to reasonably healthy financials and positive accounting-based signals.
• Sales growth of 18.04% and profit growth of 48.28% show some business momentum, though from a fragile earnings base.

Concerns

• Latest quarter generated ₹70 Cr in sales but zero net profit, exposing weak margin conversion or a possible one-off hit.
• ROE of 3.38% and ROCE of 6.70% are far below what a quality franchise should earn; assets are not generating adequate returns.
• Dividend yield is 0.00%, so shareholders receive no income while waiting for the value to be unlocked.
• Debt/Equity and promoter holding are N/A, limiting the ability to assess leverage and insider alignment.

AI Analysis

At first glance, Olympia Industri is a Graham-style value puzzle. The share price of ₹59.99 sits well below book value of ₹91.38, giving a P/B of 0.66 and a P/E of 10.52. That is the kind of arithmetic cheapness that draws my attention. But attention is not the same as investment. Book value only matters if the underlying assets can earn an acceptable return, and here the financials are mediocre. ROE is 3.38% and ROCE is 6.70%; neither suggests a franchise with pricing power or a wide moat. Sales grew 18.04% and profit reportedly jumped 48.28%, leading to a PEG of 0.32. Those are tempting numbers, yet the latest quarter undermines them: ₹70 crore in sales produced zero net profit. A zero-profit quarter can be noisy, but it screams that margins are fragile. The Piotroski F-Score of 7/9 is a small reassurance that the balance sheet has not deteriorated, but I cannot ignore missing data on promoter holding and debt. I also see no dividend, so the shareholder must wait indefinitely for value to emerge. The stock trades at the top of its 52-week range, so the market is not entirely pessimistic. Still, a low P/B with low returns is often a value trap, not a bargain. Olympia needs to convert its growth into real earnings, lift ROE and ROCE, and prove the latest quarter was an exception. Until then, I would classify this as a possible asset play with a hidden catalyst, not a compounding machine. I will watch from the sidelines and demand evidence of earning power before putting my money beside yours.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer